Ascentage Pharma Group International

Ascentage Pharma Group International is a global clinical-stage biotechnology company that specializes in developing innovative therapies for cancers, hepatitis B, age-related diseases, and other chronic conditions. The company leverages its industry expertise to focus on novel research platforms addressing key molecular pathways involved in disease. Headquartered in China, Ascentage Pharma operates with a commitment to advancing scientific understanding and clinical potential in targeted therapy and immuno-oncology. Their pipeline includes apoptosis-targeting drug candidates, which aim to selectively induce cancer cell death, thereby providing new treatment possibilities for patients with unmet medical needs. The company's influential role in the biotechnology landscape is underscored by its collaborations with top-tier pharmaceutical firms and research institutions worldwide, bolstering its research capabilities and expanding its reach. Ascentage Pharma's significant investments in R&D and clinical trials support its mission to pioneer advances in disease treatment and contribute to the global healthcare ecosystem.